DUBLIN--(BUSINESS WIRE)--Aug 24, 2018--The “Migraine Drugs Market by Type, Route of Administration, and Distribution Channel - Global Opportunity Analysis and Industry Forecast, 2018-2025” report has been added to ResearchAndMarkets.com’s offering.
The global migraine drugs market was valued at $1,713 million in 2017, and is expected to reach $2,190 million by 2025, growing at a CAGR of 3.1% from 2018 to 2025.
Rise in awareness among patients for migraine treatment & prevention, rapid increase in female population, and surge in prevalence of migraine drive the growth of the global migraine drugs market. However, side effects associated with migraine drugs limit the market growth. On the contrary, growth opportunities in the developing nations and emerging new therapies for migraine treatment are expected to present opportunities for the market growth during the forecast period.
Key BenefitsThis report entails a detailed quantitative analysis of the overall market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of the global migraine drugs market. Market size and estimations are based on comprehensive analysis of the applications and developments in the industry. An in-depth analysis based on region is provided to understand the regional market and facilitate the strategic business planning. The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
Key PlayersAbbott Laboratories Allergan PLC AstraZeneca Eisai Co. Ltd. Endo International PLC GlaxoSmithKline PLC Impax Laboratories Johnson & Johnson Merck & Co. Pfizer Inc.
Other PlayersNovartis International AG Teva Pharmaceutical Industries Limited Sanofi SA
Key Topics Covered
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
Chapter 4: Migraine Drugs Market, by Type
Chapter 5: Migraine Drugs Market, by Route of Administration
Chapter 6: Migraine Drugs Market, by Distribution Channel
Chapter 7: Migraine Drugs Market, by Region
Chapter 8: Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/fsv2vs/the_global_market?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180824005084/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Central Nervous System Drugs,Analgesics
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/24/2018 04:55 AM/DISC: 08/24/2018 04:55 AM